ENTRY       D01277                      Drug
NAME        Droxidopa (JP18/USAN/INN);
            Dops (TN);
            Northera (TN)
PRODUCT     NORTHERA (Lundbeck Pharmaceuticals LLC)
  GENERIC   DROXIDOPA (Ajanta Pharma USA)
            DROXIDOPA (Ascend Laboratories)
            DROXIDOPA (Aurobindo Pharma Limited)
            DROXIDOPA (Bionpharma)
            DROXIDOPA (CELLTRION USA)
            DROXIDOPA (Camber Pharmaceuticals)
            DROXIDOPA (Golden State Medical Supply)
            DROXIDOPA (Hikma Pharmaceuticals USA)
            DROXIDOPA (Lupin Pharmaceuticals)
            DROXIDOPA (MSN LABORATORIES PRIVATE LIMITED)
            DROXIDOPA (Novadoz Pharmaceuticals LLC)
            DROXIDOPA (ScieGen Pharmaceuticals)
            DROXIDOPA (Slate Run Pharmaceuticals)
            DROXIDOPA (Sun Pharmaceutical Industries)
            DROXIDOPA (Tris Pharma)
            DROXIDOPA (Upsher-Smith Laboratories)
            DROXIDOPA (Zydus Lifesciences Limited)
            DROXIDOPA (Zydus Pharmaceuticals USA)
FORMULA     C9H11NO5
EXACT_MASS  213.0637
MOL_WEIGHT  213.1873
CLASS       Neuropsychiatric agent
             DG01967  Antiparkinson agent
REMARK      Therapeutic category: 1169
            ATC code: C01CA27
            Product: D01277<JP/US>
EFFICACY    Antiparkinsonian, Replenisher (noradrenalin)
  DISEASE   Parkinson disease [DS:H00057]
            Multiple system atrophy [DS:H01614]
            Dopamine beta-hydroxylase deficiency [DS:H01005]
COMMENT     precursor of Norepinephrine [DR:D00076]
TARGET      ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
            ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]
  PATHWAY   hsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes
INTERACTION  
STR_MAP     map07057  Antiparkinsonian agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
                C01CA Adrenergic and dopaminergic agents
                 C01CA27 Droxidopa
                  D01277  Droxidopa (JP18/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Alpha-adrenergic Agonists
               Droxidopa
                D01277  Droxidopa (JP18/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D01277  Droxidopa (JP18/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D01277  Droxidopa
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D01277  Droxidopa
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D01277  Droxidopa (JP18/USAN/INN) &lt;JP/US&gt;
                ADRA2
                 D01277  Droxidopa (JP18/USAN/INN) &lt;JP/US&gt;
                ADRB
                 D01277  Droxidopa (JP18/USAN/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01277  Droxidopa
              D01277  Droxidopa capsules
              D01277  Droxidopa fine granules
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01277
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01277
DBLINKS     CAS: 23651-95-8
            PubChem: 7848340
            ChEBI: 31524
            LigandBox: D01277
            NIKKAJI: J22.085J
ATOM        15
            1   C8y C     5.1800   -5.1100
            2   C8y C     5.1800   -6.5100
            3   C8x C     6.4400   -7.2100
            4   C8x C     7.6300   -6.5100
            5   C8y C     7.6300   -5.1100
            6   C8x C     6.4400   -4.4100
            7   O1a O     3.9900   -7.2100
            8   C1c C     8.8200   -4.4100
            9   C1c C    10.0100   -5.1100
            10  C6a C    11.2700   -4.4100
            11  O6a O    12.4600   -5.1100
            12  O6a O    11.2700   -3.0100
            13  O1a O     8.8200   -3.0100
            14  N1a N    10.0100   -6.5100
            15  O1a O     3.9734   -4.4000
BOND        15
            1     1   2 2
            2     2   3 1
            3     5   8 1
            4     3   4 2
            5     8   9 1
            6     4   5 1
            7     9  10 1
            8     5   6 2
            9    10  11 1
            10    6   1 1
            11   10  12 2
            12    8  13 1 #Up
            13    2   7 1
            14    9  14 1 #Up
            15    1  15 1
///
